disease pathways,-0.330698
business’s revenue,-0.375138
small molecule drugs,-0.330698
Infinity Pharmaceuticals,-0.191597
email newsletter,0.547502
price objective,0.257715
hematologic malignancies,-0.321006
share,0.210916
stock,-0.0685695
consensus price target,0.436043
advanced product candidate,0.506849
email address,0.446108
related companies,0.547502
InvestorPlace Broker Center,0.555736
Infinity Pharmaceuticals Inc.,0.547502
biopharmaceutical company,0.377428
high fees,-0.735674
12-month high,-0.503045
personal trading style,0.598412
Zacks Investment Research,0.478384
potential applications,-0.330698
latest news,0.446108
average rating,-0.314266
research offerings,0.40995
JPMorgan Chase,0.257715
consensus estimate,0.203337
concise daily summary,0.446108
company,0.0467304
stock broker,0.245696
rating,-0.314266
